Stockscreener 앱 받기
279.20
2.67%
7.26
시장 영업 전:
279.20
Resmed Inc 주식(RMD)의 최신 뉴스
Is ResMed Inc. a good long term investmentAchieve breakthrough financial results - jammulinksnews.com
ResMed Inc Announces Proposed Sale of Common Shares - MSN
What is ResMed Inc. company’s growth strategyGrow your portfolio with growth-oriented stocks - jammulinksnews.com
Is ResMed Inc. a growth stock or a value stockConsistently profitable trades - jammulinksnews.com
What does JP Morgan think Resmed shares are worth after reviewing its FY25 result? - The Motley Fool Australia
What catalysts could drive ResMed Inc. stock higher in 2025Unlock exclusive trading strategies for gains - jammulinksnews.com
Does ResMed Inc. stock perform well during market downturnsInvest smarter with daily trading signals - jammulinksnews.com
What is the dividend policy of ResMed Inc. stockRapid wealth multiplication - jammulinksnews.com
How volatile is ResMed Inc. stock compared to the marketBuild wealth faster with expert stock selection - jammulinksnews.com
When is ResMed Inc. stock expected to show significant growthInvest smarter and grow your wealth faster - jammulinksnews.com
How strong is ResMed Inc. company’s balance sheetOutstanding capital returns - jammulinksnews.com
Should I hold or sell ResMed Inc. stock in 2025Market-leading capital gains - jammulinksnews.com
How does ResMed Inc. compare to its industry peersFind the best stocks for sustainable growth - jammulinksnews.com
What analysts say about ResMed Inc. stockGet daily updates on promising stocks - jammulinksnews.com
ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend - MSN
What are the technical indicators suggesting about ResMed Inc.Invest confidently with data-driven strategies - jammulinksnews.com
What makes ResMed Inc. stock price move sharplyBuild a winning investment strategy today - jammulinksnews.com
ResMed Receives Buy Rating from J.P. Morgan with A$48 Price Target - AInvest
ResMed's Q4 2025: Unpacking Contradictions in Gross Margin, Market Growth, and FX Impact - AInvest
US$290That's What Analysts Think ResMed Inc. (NYSE:RMD) Is Worth After These Results - Yahoo Finance
A Quick Look at Today's Ratings for ResMed(RMD.US), With a Forecast Between $290 to $325 - 富途牛牛
ResMed's Q4 Earnings Signal a Sleep Tech Titan's Unstoppable Momentum - AInvest
ResMed Earnings Call: Strong Growth and Strategic Vision - TipRanks
ResMed share price hits record high on strong FY25 results - MSN
Why Capstone Copper, Flight Centre, ResMed, and SKS shares are pushing higher today - MSN
ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings - Benzinga
ResMed Stock Rises After Strong Q4 Earnings Beat ExpectationsNews and Statistics - IndexBox
ResMed (RMD) Stock Is Up, What You Need To Know - FinancialContent
ResMed Earnings: Solid Gross Margin Expansion and US Mask Sales Drive Growth - Morningstar
ResMed (RMD) Price Target Increased by Piper Sandler to $270 - GuruFocus
ResMed's Moat Is Underpinned by Switching Costs and Intangible Brand Assets - Morningstar
ResMed (RMD) Price Target Increased by Baird Analyst Amid Strong Fundamentals - GuruFocus
ResMed (RMD) Price Target Raised by UBS Analyst - GuruFocus
ResMed (RMD) Sees Price Target Raised by Keybanc Analyst | RMD S - GuruFocus
A Quick Look at Today's Ratings for ResMed(RMD.US), With a Forecast Between $298 to $325 - 富途牛牛
ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript - Insider Monkey
ResMed (RMD) Price Target Raised by KeyBanc on Growth Outlook - GuruFocus
ResMed price target raised to $325 from $285 at UBS - TipRanks
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb - Yahoo Finance
Earnings call transcript: ResMed’s Q4 2025 shows strong EPS, stock dips post-call - Investing.com
ResMed Inc (RMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions - Yahoo Finance
ResMed Inc (RMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions By GuruFocus - Investing.com Canada
Global demand helps push ResMed shares to record high - inkl
Resmed Inc. Reports Strong Q4 2025 Earnings Growth - TipRanks
Resmed Australia shares hit record high on strong earnings - Investing.com
Resmed Australia shares hit record high on strong earnings By Investing.com - Investing.com India
ResMed: Result 2025 - intelligentinvestor.com.au
ResMed's ASX shares hit record on earnings beat, but is the future still bright? - Livewire Markets
ResMed: Fiscal Q4 Earnings Snapshot - Norwalk Hour
ResMed Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:RMD) - Seeking Alpha
Resmed posts Wall Street beat in Q2 - MassDevice
ResMed Q4 Earnings: Key Metrics Highlight Revenue and EPS Growth - AInvest
ResMed Q4 FY2025 slides reveal 10% revenue growth, shift to net cash position By Investing.com - Investing.com South Africa
ResMed Q4 FY2025 slides reveal 10% revenue growth, shift to net cash position - Investing.com Canada
0.37%
1.05%
자본화:
|
볼륨(24시간):